Europäischer Bronchiektasiemarkt – Branchentrends und Prognose bis 2028

Bericht anpassenBericht anpassen Jetzt kaufen Jetzt kaufen Kostenloser Beispielbericht Kostenloser Beispielbericht
Home Pharmaceutical Europe Bronchiectasis Market
Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Europäischer Bronchiektasiemarkt – Branchentrends und Prognose bis 2028

  • Pharmaceutical
  • Publish Reports
  • Mar 2021
  • Europe
  • 350 Seiten
  • Anzahl der Tabellen: 440
  • Anzahl der Abbildungen: 56
Jetzt kaufen Jetzt kaufen

Europäischer Bronchiektasiemarkt, nach Krankheitstyp (CF-Bronchiektasie und Nicht-CF-Bronchiektasie), Schweregrad (leicht bis mittelschwer und mittelschwer bis schwer), Typ (Diagnose und Behandlung), Arzneimitteltyp (Marken- und Generika), Verabreichungsweg (oral, parenteral und Inhalation), Endverbraucher (Krankenhäuser, Kliniken, häusliche Pflege und andere), Vertriebskanal (Krankenhausapotheke, Einzelhandelsapotheke, Online-Apotheke, andere), Land (Deutschland, Großbritannien, Frankreich, Italien, Spanien, Niederlande, Russland, Schweiz, Belgien, Türkei, Österreich, Norwegen, Ungarn, Litauen, Irland, Polen, übriges Europa) Branchentrends und Prognose bis 2028

Europäischer Bronchiektasie-MarktMarktanalyse und Einblicke: Europäischer Bronchiektasie-Markt

Es wird erwartet, dass der Markt für Bronchiektasien im Prognosezeitraum von 2021 bis 2028 an Marktwachstum gewinnt. Data Bridge Market Research analysiert, dass der Markt im Prognosezeitraum von 2021 bis 2028 mit einer durchschnittlichen jährlichen Wachstumsrate (CAGR) von 5,6 % wächst und bis 2028 voraussichtlich 250,46 Millionen USD erreichen wird. Die steigende Zahl der Alkoholkonsumenten und Raucher sowie der technologische Fortschritt bei der Krankheitsdiagnostik sind die Haupttreiber, die die Nachfrage auf dem Bronchiektasienmarkt im Prognosezeitraum angekurbelt haben.

Bronchiektasie ist ein Begriff, der vom griechischen Wort bronckos abgeleitet ist, das Atemwege bedeutet , und Ektasie bedeutet Erweiterung. Es handelt sich um eine chronische Lungenerkrankung, die als abnorme und irreversible Erweiterung der Bronchien definiert ist, bei der sowohl das Muskel- als auch das elastische Gewebe aufgrund einer kurz- und langfristigen Infektion zerstört werden. Die Kombination dieser Infektionen führt zu einer Schädigung einer oder beider Lungen. Die Schädigungsstelle wird durch eine hochauflösende Computertomographie (HRCT) diagnostiziert, die zeigt, dass vor allem die größeren Atemwege betroffen sind, während die Krankheit in den kleineren Atemwegen nicht gescannt wird, weshalb manche Patienten viele Jahre lang mit Symptomen zu kämpfen haben, bevor die Diagnose gestellt wird.

Die Diagnose und Behandlung von Bronchiektasien hilft Intensivpatienten, ein gesundes Leben zu führen, was es ihnen ermöglicht, ihr Leben zu retten. Dies ist der Grund für die steigende Zahl der Patienten, die an Bronchiektasien leiden, und ist der Wachstumsmotor für den Bronchiektasienmarkt. Die hohen Kosten für Diagnoseinstrumente wirken als Hemmnis für die Nachfrage auf dem Bronchiektasienmarkt. Die verstärkten Aufklärungsprogramme über Bronchiektasien sind einer der Schritte, die Organisationen und Menschen auf der ganzen Welt unternommen haben, um die Verbreitung von Bronchiektasien zu minimieren. Diese Aufklärungsprogramme können eine Chance für das Wachstum des Bronchiektasienmarktes darstellen. Die Komplikationen während der Behandlung von Bronchiektasien stellen für die Gesundheitsdienstleister eine Herausforderung dar, was das Wachstum des Bronchiektasienmarktes beeinträchtigen kann.

Der Bronchiektasie-Marktbericht enthält Einzelheiten zu Marktanteilen, neuen Entwicklungen und Produktpipeline-Analysen, Auswirkungen inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neu entstehende Umsatzbereiche, Änderungen der Marktvorschriften, Produktzulassungen, strategische Entscheidungen, Produkteinführungen, geografische Expansionen und technologische Innovationen auf dem Markt. Um die Analyse und das Bronchiektasie-Marktszenario zu verstehen, wenden Sie sich an Data Bridge Market Research, um ein Analyst Briefing zu erhalten. Unser Team hilft Ihnen dabei, eine Umsatzauswirkungslösung zu entwickeln, mit der Sie Ihr gewünschtes Ziel erreichen.

Europäischer Bronchiektasie-MarktBronchiektasie – Marktumfang und Marktgröße

Der Bronchiektasie-Markt ist segmentiert auf der Grundlage von Krankheitstyp, Schweregrad, Art, Medikamententyp, Verabreichungsweg, Endverbraucher und Vertriebskanal. Das Wachstum zwischen den Segmenten hilft Ihnen, Nischenwachstumsbereiche und Strategien zur Marktbearbeitung zu analysieren und Ihre wichtigsten Anwendungsbereiche und die Unterschiede in Ihren Zielmärkten zu bestimmen.

  • Auf der Grundlage des Krankheitstyps wird der Bronchiektasiemarkt in CF-Bronchiektasie und Nicht-CF-Bronchiektasie segmentiert. Im Jahr 2021 wird das Segment Nicht-CF-Bronchiektasie voraussichtlich den Bronchiektasiemarkt dominieren, da es zusammen mit anderen Atemwegserkrankungen wie der chronisch obstruktiven Lungenerkrankung (COPD) auftritt und bei Frauen und geriatrischer Bevölkerung weit verbreitet ist.
  • Auf der Grundlage des Schweregrads wird der Markt für Bronchiektasien in leicht bis mittelschwer und mittelschwer bis schwer unterteilt. Im Jahr 2021 wird das Segment leicht bis mittelschwer voraussichtlich den Markt für Bronchiektasien dominieren, da Bronchiektasien eine fortschreitende und chronische Atemwegserkrankung sind, die durch anhaltenden Husten, abnorm erweiterte Atemwege, übermäßige Auswurfproduktion und wiederkehrende Lungeninfektionen gekennzeichnet ist und all diese Symptome lebenslange schwere Erkrankungen darstellen.
  • Der Markt für Bronchiektasien wird nach Art in Diagnose und Behandlung unterteilt. Im Jahr 2021 wird das Behandlungssegment voraussichtlich den Bronchiektasienmarkt dominieren, da Patienten mit der Diagnose Bronchiektasien auf wirksame und neuartige Arzneimitteltherapien angewiesen sind, um ein normales, gesundes Leben führen zu können.
  • Auf der Grundlage der Medikamentenart ist der Markt für Bronchiektasie in Marken- und Generikaprodukte segmentiert. Im Jahr 2021 wird das Markensegment voraussichtlich den Bronchiektasiemarkt dominieren, da die von vielen Unternehmen angebotenen Medikamente patentierte Formulierungen sind.
  • Auf der Grundlage der Verabreichungsmethode wird der Bronchiektasiemarkt in orale, parenterale und Inhalation unterteilt. Im Jahr 2021 wird das Inhalationssegment voraussichtlich den Bronchiektasiemarkt dominieren, da die Inhalationsmethode eine effektive Verabreichung des Medikaments direkt in die Atemwege der Lunge ermöglicht und der zunehmende technologische Fortschritt bei der Einführung intelligenter Inhalatoren, mit denen Patienten eine genaue Medikamentendosierung beibehalten können, dem Markt ebenfalls ein lukratives Wachstum beschert.
  • Auf der Grundlage des Endverbrauchers ist der Bronchiektasiemarkt in Krankenhäuser , Kliniken, häusliche Pflege und andere unterteilt. Im Jahr 2021 dominiert das Krankenhaussegment den Bronchiektasiemarkt, da Krankenhäuser fortschrittliche Diagnoseinstrumente zur Diagnose der mit Bronchiektasie verbundenen Symptome bereitstellen.
  • Auf der Grundlage des Vertriebskanals ist der Bronchiektasiemarkt in Krankenhausapotheken, Einzelhandelsapotheken, Online-Apotheken und andere segmentiert. Im Jahr 2021 wird das Krankenhausapothekensegment voraussichtlich den Bronchiektasiemarkt dominieren, da Krankenhausapotheken eine breite Produktpalette entsprechend den Bedürfnissen und der Nachfrage der Patienten haben.

Europa Bronchiektasie Markt – Länderebene Analyse

Der europäische Markt für Bronchiektasien wird analysiert und Informationen zur Marktgröße werden auf Grundlage von Land, Krankheitsart, Schweregrad, Art, Arzneimitteltyp, Verabreichungsweg, Endverbraucher und Vertriebskanal, wie oben angegeben, bereitgestellt.

Die im europäischen Marktbericht zu Bronchiektasien abgedeckten Länder sind Deutschland, Großbritannien, Frankreich, Italien, Spanien, die Niederlande, Russland, die Schweiz, Belgien, die Türkei, Österreich, Norwegen, Ungarn, Litauen, Irland, Polen und das übrige Europa.

Das Segment der Nicht-CF-Bronchiektasien in der Region Europa wird im Prognosezeitraum von 2021 bis 2028 voraussichtlich die höchste Wachstumsrate aufweisen, da nicht-zystische Fibrose-Bronchiektasien häufig zusammen mit anderen Atemwegserkrankungen wie chronisch obstruktiver Lungenerkrankung auftreten. Die Prävalenz von NCFB nimmt zu, insbesondere bei Frauen und älteren Menschen. Deutschland ist führend beim Wachstum des europäischen Bronchiektasiemarktes und das Segment der Nicht-CF-Bronchiektasien dominiert in der Region aufgrund der steigenden Prävalenz von Atemwegserkrankungen. Frankreich ist aufgrund zunehmender Forschung und Entwicklung das am schnellsten wachsende Land in der Region Europa. Das Vereinigte Königreich hält den drittgrößten Marktanteil in der Region Europa aufgrund zunehmender staatlicher Initiativen zur Sensibilisierung für die schweren Atemwegserkrankungen.

Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit europäischer Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.

Wachsende Diagnoserate und steigende Gesundheitsausgaben kurbeln das Wachstum des Bronchiektasie-Marktes an

Der Bronchiektasie-Markt bietet Ihnen außerdem eine detaillierte Marktanalyse für jedes Land mit Wachstum in der Bronchiektasie-Branche mit Verkäufen von Bronchiektasie-Medikamenten, Auswirkungen des Fortschritts in der Bronchiektasie-Technologie und Änderungen in regulatorischen Szenarien mit ihrer Unterstützung für den Bronchiektasie-Markt. Die Daten sind für den historischen Zeitraum 2011 bis 2019 verfügbar.

Wettbewerbsumfeld und Bronchiektasie Marktanteilsanalyse

Die Wettbewerbslandschaft des Bronchiektasiemarktes liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -einrichtungen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produkttestpipelines, Produktzulassungen, Patente, Produktbreite und -umfang, Anwendungsdominanz, Technologie-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens in Bezug auf den Bronchiektasiemarkt.

Die wichtigsten Unternehmen, die im europäischen Marktbericht für Bronchiektasien behandelt werden, sind Abbott, HERSILL, Indogen, Inc., Boehringer Ingelheim International GmbH, Medline Industries, Inc., Ache Laboratories Farmaceuticos SA, Horizon Therapeutics plc, Janssen Pharmaceuticals, Inc. (eine Tochtergesellschaft von Johnson & Johnson Services, Inc.), Trudell Medical International, GlaxoSmithKline plc, AstraZeneca, Pfizer Inc., Merck Sharp & Dohme Corp. (eine Tochtergesellschaft von Merck & Co., Inc.), Novartis AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Dr. Reddy's Laboratories Ltd., Sunovion Pharmaceuticals Inc. (eine Tochtergesellschaft von Sumitomo Dainippon Pharma Co., Ltd.), Viatris Inc., Covis Pharma, Cipla Inc. sowie andere inländische Akteure. Die Analysten von DBMR kennen die Stärken der Konkurrenz und erstellen für jeden Konkurrenten eine separate Wettbewerbsanalyse.

Darüber hinaus werden von den Unternehmen weltweit zahlreiche Produkteinführungen und Vereinbarungen initiiert, die dem Bronchiektasie-Markt ebenfalls Auftrieb verleihen.

Zum Beispiel,

  • Im Juni 2019 erhielt AstraZeneca in Japan die Zulassung für Breztri Aerosphere (PT010) zur Behandlung von COPD. Breztri Aerosphere besteht aus Budesonid/Glycopyrronium/Formoterolfumarat und hat sich als neue Behandlungsmöglichkeit für Menschen mit Lungenentzündungen und anderen chronisch obstruktiven Erkrankungen erwiesen. Diese Zulassung verhalf dem Unternehmen zu konstanten Umsätzen, indem es seinen Produktabsatz in mehreren Regionen der Welt ausweitete.

Zusammenarbeit, Produkteinführung, Geschäftsausweitung, Auszeichnungen und Anerkennungen, Joint Ventures und andere Strategien der Marktteilnehmer stärken den Unternehmensmarkt im Bronchiektasie-Markt, was den Unternehmen auch den Vorteil bietet, ihr Angebot zur Behandlung von Bronchiektasien zu verbessern.

SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Sample Image Klicken Sie auf das Bild, um es zu vergrößern
  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Inhaltsverzeichnis

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE bronchiectasis MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. disease type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET drugs type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Pipeline analysis
  5. Europe Bronchiectasis Market: Laws and regulations
  6. Epidemiology
  7. Market Overview
    1. Drivers
      1. Rising Patient Population Suffering from bronchiectasis
      2. growing geriatric population
      3. rising number of smokers and consumption of alcohol
      4. technological advancement for disease testing
      5. growing DIAGNOSTIC rate
    2. restrainTs
      1. high cost of diagnostic tools
      2. product recalls
      3. inappropriate reimbursement policies
    3. opportunities
      1. Rising awareness for prevention of bronchiectasis in primary and secondary care
      2. increasing healthcare expenditure
      3. increase in research regarding the bronchiectasis disease
      4. availability of generic drugs in underdeveloped and developing countries
    4. challenges
      1. complications in the treatment of bronchiectasis
      2. lack of skilled professionals
      3. diagnositic challenges
  8. IMPACT OF COVID-19
    1. PRICE IMPACT
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  9. europe bronchiectasis MARKET, BY disease type
    1. overview
    2. Non-CF Bronchiectasis
    3. CF Bronchiectasis
  10. europe bronchiectasis MARKET, BY severity
    1. overview
    2. mild to moderate
    3. moderate to severe
  11. europe bronchiectasis MARKET, BY type
    1. overview
    2. treatment
      1. Antibiotics
        1. MACROLIDE
          1. AZITHROMYCIN
          2. CLARITHROMYCIN
          3. OTHERS
        2. AMOXICILLIN
        3. CEPHALOSPORIN
          1. SECOND-GENERATION CEPHALOSPORIN
          2. THIRD-GENERATION CEPHALOSPORIN
        4. AMINOGLYCOSIDE
          1. GENTAMICIN
          2. TOBRAMYCIN
        5. FLUOROQUINOLONE
        6. TETRACYCLINS
        7. TRIMETHOPRIM-SULFAMETHOXAZOLE
        8. COMBINATION THERAPY
      2. Corticosteroids
        1. BUDESONIDE
        2. FLUTICASONE
        3. MOMETASONE
        4. FLUNISOLIDE
        5. OTHERS
      3. Bronchodilators
        1. LONG-ACTING BRONCHODILATORS
          1. FORMOTEROL
          2. TIOTROPIUM
          3. SALMETEROL
          4. OTHERS
        2. SHORT-ACTING BRONCHODILATORS
          1. ALBUTEROL
          2. LEVALBUTEROL
          3. OTHERS
      4. Mucus Thinning Medicine
        1. CARBOCISTEINE
        2. BROMHEXINE
        3. OTHERS
      5. Airway Clearance Devices
        1. OSCILLATING POSITIVE EXPIRATORY PRESSURE (PEP)
        2. INTRAPULMONARY PERCUSSIVE VENTILATION (IPV)
        3. POSTURAL DRAINAGE
        4. OTHERS
      6. Oxygen Therapy
        1. OXYGEN CONCENTRATORS
        2. COMPRESSED GAS OXYGEN
        3. LIQUID OXYGEN
      7. Surgery
        1. BRONCHOSCOPY
        2. LUNG TRANSPLANT
      8. Others
    3. diagnosis
      1. Chest CT Scan
      2. Sputum Test
      3. Pulmonary Function Test
      4. X-Ray
      5. Others
  12. europe bronchiectasis MARKET, BY drugs type
    1. overview
    2. branded
    3. generics
  13. europe bronchiectasis MARKET, BY route of administration
    1. overview
    2. inhalation
    3. oral
      1. Tablets
      2. Capsules
      3. Others
    4. parenteral
      1. Intravenous
      2. Subcutaneous
      3. Others
  14. europe bronchiectasis MARKET, BY end user
    1. overview
    2. hospitals
    3. clinics
    4. home healthcare
    5. others
  15. europe bronchiectasis MARKET, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online pharmacy
    5. others
  16. Europe Bronchiectasis Market by geography
    1. Overview
    2. EUROPE
      1. germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. NETHERLANDS
      7. Russia
      8. Switzerland
      9. Belgium
      10. Turkey
      11. Austria
      12. Norway
      13. Hungary
      14. Lithuania
      15. Ireland
      16. Poland
      17. Rest of Europe
  17. Europe Bronchiectasis Market: COMPANY landscape
    1. company share analysis: europe
  18. SWOT
  19. Company profiles
    1. AstraZeneca
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. GlaxoSmithKline plc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Merck Sharp & Dohme Corp. (A subsidiary of Merck & Co., Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. Ache Laboratories Farmaceuticos S.A.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Bayer AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. boehringer ingelheim international gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Cipla Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Covis Pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    12. Dr. Reddy’s Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. Electromed, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. hersill
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. home oxygen company
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. horizon therapeutics plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    17. inogen, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. medline industries, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. Pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. Sunovion Pharmaceuticals Inc. (A Subsidiary of Sumitomo Dainippon Pharma Co., Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    22. Sun Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    23. truedell medical international
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    24. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    25. Zydus Pharmaceuticals, Inc. (A subsidiary of Zydus Cadila)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  20. questionnaire
  21. related reports

Tabellenverzeichnis

TABLE 1 Europe bronchiectasis Market, pipeline analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Healthcare expenditure in asia-pacific

TABLE 4 THE PRICE OF X-RAY MACHINE

TABLE 5 Europe Bronchiectasis Market, By Disease Type, 2019-2028 (USD Million)

TABLE 6 Europe Non-CF Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 7 Europe CF Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 8 Europe Bronchiectasis Market, By Severity, 2019-2028 (USD Million)

TABLE 9 Europe Mild to Moderate Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 10 Europe Moderate to Severe Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 11 Europe Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 12 europe treatment in bronchiectasis Market, By Region, 2017-2028 (USD Million)

TABLE 13 Europe Treatment in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 14 Europe Treatment by Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 15 Europe Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 16 Europe Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 17 Europe Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 18 Europe Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 19 Europe Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 20 Europe Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 21 Europe Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 22 Europe Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 23 Europe Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 24 Europe Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 25 Europe Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 26 europe diagnosis in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 28 Europe Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 29 europe branded in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 30 europe generics in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 31 Europe Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 32 Europe Inhalation in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 33 Europe Oral in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 34 Europe Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 35 Europe Parenteral in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 36 Europe Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 37 Europe Bronchiectasis Market, By End User, 2019-2028 (USD Million)

TABLE 38 europe hospitals in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 39 europe clinics in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 40 europe home healthcare in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 41 europe others in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 42 Europe Bronchiectasis Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 Europe Hospital Pharmacy in Bronchiectasis Market, region, 2019-2028 (USD Million)

TABLE 44 Europe Retail Pharmacy in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 45 Europe Online Pharmacy in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 46 Europe Others in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 47 EUROPE BRONCHIECTASIS MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 48 EUROPE BRONCHIECTASIS MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 49 Europe BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 50 Europe BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 51 Europe BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 52 Europe treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 53 Europe treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 54 Europe Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 55 Europe Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 56 Europe Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 57 Europe Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 58 Europe Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 59 Europe Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 60 Europe Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 61 Europe Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 62 Europe Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 63 Europe Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 64 Europe Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 65 Europe Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 66 Europe Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 67 Europe Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 68 Europe Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 69 Europe Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 70 Europe BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 71 Europe BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 72 GERMANY BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 73 GERMANY BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 74 GERMANY BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 75 GERMANY treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 76 GERMANY treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 77 GermanyTreatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 78 GERMANY Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 79 Germany Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 80 Germany Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 81 Germany Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 82 Germany Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 83 Germany Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 84 Germany Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 85 Germany Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 86 Germany Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 87 Germany Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 88 Germany Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 89 Germany Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 90 Germany Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 91 Germany Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 92 Germany Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 93 Germany BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 94 Germany BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 95 France BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 96 France BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 97 France BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 98 France treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 99 France treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 100 France Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 101 France Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 102 France Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 103 France Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 104 France Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 105 France Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 106 France Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 107 France Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 108 France Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 109 France Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 110 France Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 111 France Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 112 France Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 113 France Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 114 France Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 115 France Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 116 France BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 117 France BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 118 U.K. BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 119 U.K. BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 120 U.K. BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 121 U.K. treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 122 U.K. treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 123 U.K. Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 124 U.K. Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 125 U.K. Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 126 U.K. Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 127 U.K. Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 128 U.K. Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 129 U.K. Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 130 U.K. Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 131 U.K. Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 132 U.K. Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 133 U.K. Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 134 U.K. Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 135 U.K. Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 136 U.K. Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 137 U.K. Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 138 U.K. Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 139 U.K. BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 140 U.K. BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 141 Italy BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 142 Italy BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 143 Italy BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 144 Italy treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 145 Italy treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 146 Italy Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 147 Italy Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 148 Italy Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 149 Italy Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 150 Italy Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 151 Italy Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 152 Italy Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 153 Italy Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 154 Italy Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 155 Italy Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 156 Italy Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 157 Italy Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 158 Italy Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 159 Italy Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 160 Italy Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 161 Italy Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 162 Italy BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 163 Italy BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 164 Spain BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 165 Spain BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 166 Spain BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 167 Spain treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 168 Spain treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 169 Spain Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 170 Spain Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 171 Spain Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 172 Spain Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 173 Spain Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 174 Spain Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 175 Spain Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 176 Spain Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 177 Spain Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 178 Spain Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 179 Spain Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 180 Spain Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 181 Spain Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 182 Spain Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 183 Spain Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 184 Spain Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 185 Spain BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 186 Spain BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 187 Netherlands BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 188 Netherlands BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 189 Netherlands BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 190 Netherlands treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 191 Netherlands treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 192 Netherlands Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 193 Netherlands Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 194 Netherlands Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 195 Netherlands Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 196 Netherlands Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 197 Netherlands Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 198 Netherlands Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 199 Netherlands Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 200 Netherlands Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 201 Netherlands Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 202 Netherlands Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 203 Netherlands Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 204 Netherlands Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 205 Netherlands Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 206 Netherlands Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 207 Netherlands Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 208 Netherlands BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 209 Netherlands BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 210 Russia BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 211 Russia BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 212 Russia BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 213 Russia treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 214 Russia treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 215 Russia Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 216 Russia Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 217 Russia Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 218 Russia Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 219 Russia Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 220 Russia Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 221 Russia Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 222 Russia Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 223 Russia Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 224 Russia Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 225 Russia Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 226 Russia Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 227 Russia Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 228 Russia Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 229 Russia Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 230 Russia Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 231 Russia BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 232 Russia BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 233 Switzerland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 234 Switzerland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 235 Switzerland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 236 Switzerland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 237 Switzerland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 238 Switzerland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 239 Switzerland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 240 Switzerland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 241 Switzerland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 242 Switzerland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 243 Switzerland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 244 Switzerland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 245 Switzerland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 246 Switzerland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 247 Switzerland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 248 Switzerland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 249 Switzerland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 250 Switzerland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 251 Switzerland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 252 Switzerland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 253 Switzerland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 254 Switzerland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 255 Switzerland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 256 Belgium BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 257 Belgium BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 258 Belgium BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 259 Belgium treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 260 Belgium treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 261 Belgium Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 262 Belgium Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 263 Belgium Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 264 Belgium Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 265 Belgium Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 266 Belgium Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 267 Belgium Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 268 Belgium Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 269 Belgium Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 270 Belgium Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 271 Belgium Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 272 Belgium Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 273 Belgium Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 274 Belgium Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 275 Belgium Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 276 Belgium Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 277 Belgium BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 278 Belgium BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 279 Turkey BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 280 Turkey BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 281 Turkey BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 282 Turkey treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 283 Turkey treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 284 Turkey Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 285 Turkey Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 286 Turkey Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 287 Turkey Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 288 Turkey Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 289 Turkey Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 290 Turkey Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 291 Turkey Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 292 Turkey Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 293 Turkey Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 294 Turkey Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 295 Turkey Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 296 Turkey Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 297 Turkey Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 298 Turkey Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 299 Turkey Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 300 Turkey BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 301 Turkey BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 302 Austria BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 303 Austria BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 304 Austria BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 305 Austria treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 306 Austria treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 307 Austria Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 308 Austria Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 309 Austria Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 310 Austria Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 311 Austria Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 312 Austria Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 313 Austria Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 314 Austria Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 315 Austria Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 316 Austria Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 317 Austria Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 318 Austria Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 319 Austria Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 320 Austria Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 321 Austria Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 322 Austria Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 323 Austria BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 324 Austria BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 325 Norway BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 326 Norway BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 327 Norway BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 328 Norway treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 329 Norway treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 330 Norway Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 331 Norway Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 332 Norway Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 333 Norway Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 334 Norway Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 335 Norway Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 336 Norway Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 337 Norway Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 338 Norway Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 339 Norway Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 340 Norway Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 341 Norway Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 342 Norway Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 343 Norway Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 344 Norway Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 345 Norway Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 346 Norway BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 347 Norway BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 348 Hungary BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 349 Hungary BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 350 Hungary BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 351 Hungary treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 352 Hungary treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 353 Hungary Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 354 Hungary Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 355 Hungary Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 356 Hungary Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 357 Hungary Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 358 Hungary Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 359 Hungary Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 360 Hungary Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 361 Hungary Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 362 Hungary Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 363 Hungary Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 364 Hungary Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 365 Hungary Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 366 Hungary Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 367 Hungary Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 368 Hungary Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 369 Hungary BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 370 Hungary BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 371 Lithuania BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 372 Lithuania BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 373 Lithuania BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 374 Lithuania treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 375 Lithuania treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 376 Lithuania Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 377 Lithuania Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 378 Lithuania Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 379 Lithuania Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 380 Lithuania Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 381 Lithuania Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 382 Lithuania Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 383 Lithuania Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 384 Lithuania Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 385 Lithuania Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 386 Lithuania Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 387 Lithuania Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 388 Lithuania Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 389 Lithuania Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 390 Lithuania Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 391 Lithuania Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 392 Lithuania BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 393 Lithuania BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 394 Ireland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 395 Ireland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 396 Ireland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 397 Ireland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 398 Ireland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 399 Ireland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 400 Ireland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 401 Ireland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 402 Ireland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 403 Ireland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 404 Ireland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 405 Ireland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 406 Ireland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 407 Ireland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 408 Ireland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 409 Ireland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 410 Ireland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 411 Ireland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 412 Ireland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 413 Ireland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 414 Ireland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 415 Ireland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 416 Ireland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 417 Poland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 418 Poland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 419 Poland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 420 Poland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 421 Poland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 422 Poland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 423 Poland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 424 Poland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 425 Poland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 426 Poland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 427 Poland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 428 Poland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 429 Poland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 430 Poland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 431 Poland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 432 Poland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 433 Poland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 434 Poland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 435 Poland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 436 Poland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 437 Poland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 438 Poland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 439 Poland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 440 rest of Europe BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

Abbildungsverzeichnis

FIGURE 1 Europe BRONCHIECTASIS MARKET: SEGMENTATION

FIGURE 2 EUROPE BRONCHIECTASIS MARKET : DATA TRIANGULATION

FIGURE 3 europe Bronchiectasis Market: DROC ANALYSIS

FIGURE 4 Europe Bronchiectasis market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Bronchiectasis Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Bronchiectasis MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Bronchiectasis MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE BRONCHIECTASIS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE BRONCHIECTASIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE bronchiectasis MARKET: MARKET drugs type COVERAGE GRID

FIGURE 11 Europe Bronchiectasis market: SEGMENTATION

FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM BRONCHIECTASIS is DRIVing THE europe Bronchiectasis MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 NON-CF BRONCHIECTASIS SEGMENT is expected to account for the largest share of the europe BRONCHIECTASIS MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Bronchiectasis market

FIGURE 15 Number of Persons Aged 60 Years Across Several Regions in 2017 and 2050

FIGURE 16 prevalence of bronchiectasis by age in korea population (2019)

FIGURE 17 Health Spending by Major Sources of Funds

FIGURE 18 europe bronchiectasis market: BY disease type, 2021

FIGURE 19 europe bronchiectasis market: BY disease type, 2019-2028 (USD Million)

FIGURE 20 europe bronchiectasis market: BY disease type, CAGR (2021-2028)

FIGURE 21 europe bronchiectasis market: BY disease type, LIFELINE CURVE

FIGURE 22 europe bronchiectasis market: BY severity, 2021

FIGURE 23 europe bronchiectasis market: BY severity, 2019-2028 (USD Million)

FIGURE 24 europe bronchiectasis market: BY severity, CAGR(2021-2028)

FIGURE 25 europe bronchiectasis market: BY severity, LIFELINE CURVE

FIGURE 26 europe bronchiectasis market: BY type, 2021

FIGURE 27 europe bronchiectasis market: BY type, 2019-2028 (USD Million)

FIGURE 28 europe bronchiectasis market: BY type, CAGR (2021-2028)

FIGURE 29 europe bronchiectasis market: BY type, LIFELINE CURVE

FIGURE 30 europe bronchiectasis market: BY drugs type, 2021

FIGURE 31 europe bronchiectasis market: BY drugs type, 2019-2028 (USD Million)

FIGURE 32 europe bronchiectasis market: BY drugs type, CAGR (2021-2028)

FIGURE 33 europe bronchiectasis market: BY drugs type, LIFELINE CURVE

FIGURE 34 europe bronchiectasis market: BY route of administration, 2021

FIGURE 35 europe bronchiectasis market: BY route of administration, 2019-2028 (USD Million)

FIGURE 36 europe bronchiectasis market: BY route of administration, CAGR (2021-2028)

FIGURE 37 europe bronchiectasis market: BY route of administration, LIFELINE CURVE

FIGURE 38 europe bronchiectasis market: BY end user, 2021

FIGURE 39 europe bronchiectasis market: BY end user, 2019-2028 (USD Million)

FIGURE 40 europe bronchiectasis market: BY end user, CAGR (2021-2028)

FIGURE 41 europe bronchiectasis market: BY end user, LIFELINE CURVE

FIGURE 42 europe bronchiectasis market: BY distribution channel, 2021

FIGURE 43 europe bronchiectasis market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 44 europe bronchiectasis market: BY distribution channel, CAGR (2021-2028)

FIGURE 45 europe bronchiectasis market: BY distribution channel, LIFELINE CURVE

FIGURE 46 EUROPE BRONCHIECTASIS market: SNAPSHOT (2020)

FIGURE 47 EUROPE BRONCHIECTASIS market: BY COUNTRY (2020)

FIGURE 48 EUROPE BRONCHIECTASIS market: BY COUNTRY (2021 & 2028)

FIGURE 49 EUROPE BRONCHIECTASIS market: BY COUNTRY (2020 & 2028)

FIGURE 50 EUROPE BRONCHIECTASIS market: BY Disease type (2021-2028)

FIGURE 51 Europe BRONCHIECTASIS market: SNAPSHOT (2020)

FIGURE 52 Europe BRONCHIECTASIS market: BY COUNTRY (2020)

FIGURE 53 Europe BRONCHIECTASIS market: BY COUNTRY (2021 & 2028)

FIGURE 54 Europe BRONCHIECTASIS market: BY COUNTRY (2020 & 2028)

FIGURE 55 Europe BRONCHIECTASIS market: BY Disease type (2021-2028)

FIGURE 56 Europe Bronchiectasis market: company share 2020 (%)

Detaillierte Informationen anzeigen Right Arrow

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Verwandte Seiten durchsuchen

Banner